Cargando…

A randomized multicenter Phase Ib/II study to assess the immunological effect of chemoradiation therapy (CRT) in combination with pembrolizumab compared to CRT alone in resectable or borderline resectable pancreatic cancer

Detalles Bibliográficos
Autores principales:	Katz, Matthew, Todd, Bauer W, Varadhachary, Gauri, Acquavella, Nicolas, Petroni, Gina, Bullock, Timothy, Slingluff, Craig L, Rahma, Osama
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645992/ http://dx.doi.org/10.1186/2051-1426-3-S2-P167

Ejemplares similares

Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinoma
por: Katz, Matthew H G, et al.
Publicado: (2023)

CRT-D or CRT-P in CRT-indicated patients?
por: Kaya, Adnan, et al.
Publicado: (2017)

CRT-D or CRT-P?: the endless debate!
por: Daubert, J Claude
Publicado: (2023)

The risk of ventricular arrhythmias in a Dutch CRT population: CRT-defibrillator versus CRT-pacemaker
por: ter Horst, I. A. H., et al.
Publicado: (2016)

Consolidation chemotherapy during neoadjuvant chemoradiation (CRT) for distal rectal cancer leads to sustained decrease in tumor metabolism when compared to standard CRT regimen
por: Habr-Gama, Angelita, et al.
Publicado: (2016)

The universal CRT controller
por: Lips, R
Publicado: (1984)

Role of echocardiography in CRT
por: Tayal, Bhupendar, et al.
Publicado: (2018)

Virtual Works for CRT()
por: Waksman, Ron
Publicado: (2021)

Prognosis of CRT-treated and CRT-untreated unselected population with LBBB in Stockholm County
por: Gatti, Paolo, et al.
Publicado: (2023)

Follow-up of CRT-D patients downgraded to CRT-P at the time of generator exchange
por: Frey, Simon Martin, et al.
Publicado: (2023)

Computed Tomography–Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic Cancer
por: Koay, Eugene J., et al.
Publicado: (2019)

Image performance in CRT displays
por: Compton, Kenneth
Publicado: (2003)

Outcomes of Neoadjuvant Chemoradiation With and Without Systemic Chemotherapy in Resectable and Borderline Resectable Pancreatic Adenocarcinoma
por: Trinh, Katherine V., et al.
Publicado: (2020)

The Dosimetric Comparisons of CRT, IMRT, ARC, CRT+IMRT, and CRT+ARC of Postoperative Radiotherapy in IIIA-N2 Stage Non-Small-Cell Lung Cancer Patients
por: Zhang, Yanqiu, et al.
Publicado: (2019)

Clinical decision tool for CRT-P vs. CRT-D implantation: Findings from PROSE-ICD
por: Nauffal, Victor, et al.
Publicado: (2017)

CRT device for the analysis of Mirabelle pictures
por: Bourdinaud, M, et al.
Publicado: (1974)

Patients predict their own outcome with CRT
por: Kronborg, M.B., et al.
Publicado: (2015)

CRT 2020, COVID-19 and Beyond()
por: Waksman, Ron
Publicado: (2020)

Adaptive CRT algorithm and electrical synchrony
por: Bank, A, et al.
Publicado: (2023)

Creatine Transporter (CrT; Slc6a8) Knockout Mice as a Model of Human CrT Deficiency
por: Skelton, Matthew R., et al.
Publicado: (2011)

Visualization of the SyncAV(®) Algorithm for CRT Optimization by Non-invasive Imaging of Cardiac Electrophysiology: NICE-CRT Trial
por: Spitaler, Philipp, et al.
Publicado: (2023)

Improvement in CRT: new strategies, better choices
por: van der Wall, E. E.
Publicado: (2014)

BLOCK-HF: CRT gains new ground
por: ElGuindy, Ahmed M., et al.
Publicado: (2013)

Upgrading and replacement in CRT devices: experience counts
por: de Voogt, W.G.
Publicado: (2015)

Echo response and clinical outcome in CRT patients
por: van ’t Sant, J., et al.
Publicado: (2015)

Dr. Colin R. Tribe: C.R.T.
Publicado: (1984)

Statistical ranking of electromechanical dyssynchrony parameters for CRT
por: Cazeau, Serge, et al.
Publicado: (2019)

Ventricular Pacing of Conventional Pacemakers in the Era of CRT
por: Galvão Filho, Silas dos Santos
Publicado: (2019)

When limited by cost in CRT-be a leftist!
por: Vyas, Aniruddha, et al.
Publicado: (2017)

Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation
por: Katz, Matthew H. G., et al.
Publicado: (2010)

Real‐world behavior of CRT pacing using the AdaptivCRT algorithm on patient outcomes: Effect on mortality and atrial fibrillation incidence
por: Singh, Jagmeet P., et al.
Publicado: (2020)

Enrichment of provitamin A content in wheat (Triticum aestivum L.) by introduction of the bacterial carotenoid biosynthetic genes CrtB and CrtI
por: Wang, Cheng, et al.
Publicado: (2014)

“Are CRT upgrade procedures more complex and associated with more complications than de novo CRT implantations?” A single centre experience
por: ter Horst, I.A.H., et al.
Publicado: (2015)

Better CRT Response in Patients Who Underwent Atrioventricular Node Ablation or Upgrade From Pacemaker: A Nomogram to Predict CRT Response
por: Xiao, Pei-Lin, et al.
Publicado: (2021)

Leadless left ventricular endocardial pacing for CRT upgrades in previously failed and high-risk patients in comparison with coronary sinus CRT upgrades
por: Sidhu, Baldeep Singh, et al.
Publicado: (2021)

DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderline resectable pancreatic cancer
por: Hasegawa, Shinichiro, et al.
Publicado: (2023)

Contralateral Pneumothorax in Left Sided CRT Device Implantation
por: Divakara Menon, Syamkumar M, et al.
Publicado: (2011)

Comparison of 3D CRT and IMRT Tratment Plans
por: Bakiu, Erjona, et al.
Publicado: (2013)

CRT-D implantation: one procedure, two problems
por: Engel, Anna M., et al.
Publicado: (2016)

DDD pacemaker for severe heart failure-alternate to CRT
por: Krishnamani, N.C.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_q3kt6nekrmqg9t813thc263o7v